Sign Up to like & get
recommendations!
1
Published in 2021 at "Cancers"
DOI: 10.3390/cancers13112757
Abstract: Simple Summary The benefit–risk assessments of new drugs for breast cancer (BC) face several challenges, as all stakeholders do not agree on the evidence bar required for market authorization, and by the fragmentation of breast…
read more here.
Keywords:
confirmatory trials;
breast;
breast cancer;
methods designs ... See more keywords